Physician

Fabian R. Franco, M.D.

According to 2025 Medicare claims, Fabian Franco, M.D. (NPI: 1649237207) practices internal medicine in the Warner Robins, GA market, with the plurality of this provider's patient population coming from Houston, GA. This provider's primary affiliated billing organization is INTERNAL MEDICINE & GERIATRICS OF HOUSTON, LLC (NPI: 1730385402; TIN: 26-0299290) and primary practice location at 31093-3622. Franco is affiliated with the TC2, LLC (ACO ID: A3365), participating under the MSSP model.

Franco's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,054 traditional Medicare patients, billed 6,504 HCPCS/CPT codes, and received $342,517 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 9,711 prescription claims across 749 beneficiaries totaling $952,992 in drug costs, led by Eliquis (Apixaban). DME data shows 663 claims. Open Payments data shows 24 records totaling $435. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $277,901 to $952,992. For DME billing, reported payments moved sharply higher in recent years, from $19,276 to $95,258.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	941	11,480	$479,922
2016	984	12,015	$541,346
2017	1,054	12,718	$538,717
2018	1,140	13,526	$580,859
2019	1,126	11,614	$485,642
2020	1,088	8,703	$413,237
2021	1,119	7,185	$380,251
2022	1,117	6,977	$368,860
2023	1,099	9,191	$552,812
2024	1,054	6,504	$342,517

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	370	5,306	$277,901
2016	372	4,262	$228,909
2017	415	3,404	$200,669
2018	481	4,113	$285,111
2019	512	6,635	$497,537
2020	537	7,824	$644,966
2021	579	7,205	$677,461
2022	585	6,082	$651,516
2023	609	6,981	$840,466
2024	749	9,711	$952,992

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	168	605	$16,369
2016	97	543	$13,628
2017	65	509	$14,294
2018	90	502	$12,965
2019	45	375	$10,622
2020	38	266	$6,522
2021	55	358	$18,022
2022	91	440	$29,103
2023	132	780	$67,334
2024	147	663	$63,333

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	829	829	$121
99497	Advance care planning, first 30 minutes	299	300	$71
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	397	514	$64
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	706	1,642	$58
G0444	Annual depression screening, 5 to 15 minutes	839	842	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	215	11,547	$219,560
Ozempic	Semaglutide	75	3,424	$104,515
Farxiga	Dapagliflozin Propanediol	81	4,710	$80,394
Januvia	Sitagliptin Phosphate	72	4,200	$64,513
Mounjaro	Tirzepatide	46	1,792	$61,357

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	24	96	$43,803
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	12	65	$4,353
A7030	Full face mask used with positive airway pressure device, each	N	13	35	$2,592
A7031	Face mask interface, replacement for full face mask, each	N	11	31	$2,508
A7032	Cushion for use on nasal mask interface, replacement only, each	N	N/R	14	$1,526

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	24	$435	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Fabian R. Franco, M.D.?

Tedicare shows public-source Medicare data for Fabian R. Franco, M.D. (NPI 1649237207), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Fabian R. Franco, M.D. have ACO affiliation data?

Fabian R. Franco, M.D. is shown with ACO affiliation data for TC2, LLC (MSSP, ACO ID A3365).

What billing organization is linked to Fabian R. Franco, M.D.?

Fabian R. Franco, M.D. is linked to INTERNAL MEDICINE & GERIATRICS OF HOUSTON, LLC (billing NPI 1730385402) in the available physician profile data.

Does Fabian R. Franco, M.D. have Open Payments data?

Fabian R. Franco, M.D. has 24 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.